195 related articles for article (PubMed ID: 27182559)
1. T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.
Woodham AW; Yan L; Skeate JG; van der Veen D; Brand HH; Wong MK; Da Silva DM; Kast WM
Papillomavirus Res; 2016 Dec; 2():21-30. PubMed ID: 27182559
[TBL] [Abstract][Full Text] [Related]
2. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.
van der Vlist M; de Witte L; de Vries RD; Litjens M; de Jong MA; Fluitsma D; de Swart RL; Geijtenbeek TB
Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428
[TBL] [Abstract][Full Text] [Related]
3. Activation of CD4+ T cells by delivery of the B7 costimulatory signal on bystander antigen-presenting cells (trans-costimulation).
Ding L; Shevach EM
Eur J Immunol; 1994 Apr; 24(4):859-66. PubMed ID: 7512033
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance.
Enk AH; Angeloni VL; Udey MC; Katz SI
J Immunol; 1993 Sep; 151(5):2390-8. PubMed ID: 8103065
[TBL] [Abstract][Full Text] [Related]
5. Immunological function of Langerhans cells in HIV infection.
Matsuzawa T; Ogawa Y; Moriishi K; Shimada S; Kawamura T
J Dermatol Sci; 2017 Aug; 87(2):159-167. PubMed ID: 28433429
[TBL] [Abstract][Full Text] [Related]
6. Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.
Fahey LM; Raff AB; Da Silva DM; Kast WM
J Immunol; 2009 Mar; 182(5):2919-28. PubMed ID: 19234187
[TBL] [Abstract][Full Text] [Related]
7. Neoantigen Expression in Steady-State Langerhans Cells Induces CTL Tolerance.
Strandt H; Pinheiro DF; Kaplan DH; Wirth D; Gratz IK; Hammerl P; Thalhamer J; Stoecklinger A
J Immunol; 2017 Sep; 199(5):1626-1634. PubMed ID: 28739880
[TBL] [Abstract][Full Text] [Related]
8. Negative costimulatory molecules: the proximal of regulatory T cells?
Gong N; Zhao Y; Dong C; Chen ZK
Med Hypotheses; 2006; 67(4):841-7. PubMed ID: 16762512
[TBL] [Abstract][Full Text] [Related]
9. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
10. Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.
Da Silva DM; Woodham AW; Naylor PH; Egan JE; Berinstein NL; Kast WM
J Interferon Cytokine Res; 2016 May; 36(5):291-301. PubMed ID: 26653678
[TBL] [Abstract][Full Text] [Related]
11. Freshly isolated Langerhans cells negatively regulate naïve T cell activation in response to peptide antigen through cell-to-cell contact.
Imai Y; Hayashi N; Yasuda K; Tsutsui H; Mizutani H; Nakanishi K
J Dermatol Sci; 2008 Jul; 51(1):19-29. PubMed ID: 18367382
[TBL] [Abstract][Full Text] [Related]
12. NKT cells inhibit antigen-specific effector CD8 T cell induction to skin viral proteins.
Mattarollo SR; Yong M; Gosmann C; Choyce A; Chan D; Leggatt GR; Frazer IH
J Immunol; 2011 Aug; 187(4):1601-8. PubMed ID: 21742969
[TBL] [Abstract][Full Text] [Related]
13. CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.
Polak ME; Newell L; Taraban VY; Pickard C; Healy E; Friedmann PS; Al-Shamkhani A; Ardern-Jones MR
J Invest Dermatol; 2012 Jun; 132(6):1636-44. PubMed ID: 22377764
[TBL] [Abstract][Full Text] [Related]
14. Induction of anergy in CD8 T cells by B cell presentation of antigen.
Höllsberg P; Batra V; Dressel A; Hafler DA
J Immunol; 1996 Dec; 157(12):5269-76. PubMed ID: 8955172
[TBL] [Abstract][Full Text] [Related]
15. In vivo ultraviolet-exposed human epidermal cells activate T suppressor cell pathways that involve CD4+CD45RA+ suppressor-inducer T cells.
Baadsgaard O; Salvo B; Mannie A; Dass B; Fox DA; Cooper KD
J Immunol; 1990 Nov; 145(9):2854-61. PubMed ID: 1976706
[TBL] [Abstract][Full Text] [Related]
16. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
Mascarell L; Lombardi V; Zimmer A; Louise A; Tourdot S; Van Overtvelt L; Moingeon P
Clin Exp Allergy; 2009 Dec; 39(12):1910-9. PubMed ID: 19694757
[TBL] [Abstract][Full Text] [Related]
18. Peripheral CD8 T-cell responses to apoptotic cell proteins and peptides.
Peng YF; Elkon KB
Crit Rev Immunol; 2007; 27(4):357-65. PubMed ID: 18197814
[TBL] [Abstract][Full Text] [Related]
19. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
[TBL] [Abstract][Full Text] [Related]
20. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells.
Xu H; Banerjee A; Dilulio NA; Fairchild RL
J Immunol; 1997 May; 158(10):4721-8. PubMed ID: 9144485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
